Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew J Brenner

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
Plos One|December 29, 2015
Obesity Suppresses Estrogen Receptor Beta Expression in Breast Cancer Cells via a HER2-Mediated PathwayLaura W Bowers, Megan Wiese, Andrew J Brenner, et al.
International Journal of Molecular Sciences|January 25, 2025
Targeting Metabolic and Epigenetic Vulnerabilities in Glioblastoma with SN-38 and Rabusertib Combination TherapyJennifer Chiou, Valeria Impedovo, Yen Bao Huynh, et al.
Lasers in Surgery and Medicine|June 15, 2021
Differentiation of Brain Tumor Microvasculature From Normal Vessels Using Optical Coherence AngiographyFarah Andleeb, Nitesh Katta, Aleksandra Gruslova, et al.
Molecular Carcinogenesis|February 1, 2012
The enhancing effects of obesity on mammary tumor growth and Akt/mTOR pathway activation persist after weight loss and are reversed by RAD001Rebecca E De Angel, Claudio J Conti, Karrie E Wheatley, et al.
Surgical Neurology International|May 5, 2022
Supratentorial ependymoma, zinc finger translocation-associated fusion positive, with extensive synaptophysin immunoreactivity arising from malignant transformation of clear cell ependymoma: A case reportJacob A Bethel, Kenneth M James, Samon G Tavakoli, et al.
Frontiers in Oncology|October 13, 2022
Circulating metabolites associated with tumor hypoxia and early response to treatment in bevacizumab-refractory glioblastoma after combined bevacizumab and evofosfamideAlessia Lodi, Renu Pandey, Jennifer Chiou, et al.
Scientific Reports|January 28, 2021
Phase 2 trial of hypoxia activated evofosfamide (TH302) for treatment of recurrent bevacizumab-refractory glioblastomaAndrew J Brenner, John Floyd, Lisa Fichtel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2013
Phase I dose-escalation study of VB-111, an antiangiogenic virotherapy, in patients with advanced solid tumorsAndrew J Brenner, Yael C Cohen, Eyal Breitbart, et al.
Stem Cells (Dayton, Ohio)|January 20, 2021
Activation of estrogen receptor beta signaling reduces stemness of glioma stem cellsGangadhara R Sareddy, Uday P Pratap, Prabhakar Pitta Venkata, et al.
Journal of Neuro-Oncology|June 26, 2015
VB-111: a novel anti-vascular therapeutic for glioblastoma multiformeAleksandra Gruslova, David A Cavazos, Jessica R Miller, et al.
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Plos One|December 29, 2015
Obesity Suppresses Estrogen Receptor Beta Expression in Breast Cancer Cells via a HER2-Mediated PathwayLaura W Bowers, Megan Wiese, Andrew J Brenner, et al.
International Journal of Molecular Sciences|January 25, 2025
Targeting Metabolic and Epigenetic Vulnerabilities in Glioblastoma with SN-38 and Rabusertib Combination TherapyJennifer Chiou, Valeria Impedovo, Yen Bao Huynh, et al.
Lasers in Surgery and Medicine|June 15, 2021
Differentiation of Brain Tumor Microvasculature From Normal Vessels Using Optical Coherence AngiographyFarah Andleeb, Nitesh Katta, Aleksandra Gruslova, et al.
Molecular Carcinogenesis|February 1, 2012
The enhancing effects of obesity on mammary tumor growth and Akt/mTOR pathway activation persist after weight loss and are reversed by RAD001Rebecca E De Angel, Claudio J Conti, Karrie E Wheatley, et al.
Surgical Neurology International|May 5, 2022
Supratentorial ependymoma, zinc finger translocation-associated fusion positive, with extensive synaptophysin immunoreactivity arising from malignant transformation of clear cell ependymoma: A case reportJacob A Bethel, Kenneth M James, Samon G Tavakoli, et al.
Frontiers in Oncology|October 13, 2022
Circulating metabolites associated with tumor hypoxia and early response to treatment in bevacizumab-refractory glioblastoma after combined bevacizumab and evofosfamideAlessia Lodi, Renu Pandey, Jennifer Chiou, et al.
Scientific Reports|January 28, 2021
Phase 2 trial of hypoxia activated evofosfamide (TH302) for treatment of recurrent bevacizumab-refractory glioblastomaAndrew J Brenner, John Floyd, Lisa Fichtel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2013
Phase I dose-escalation study of VB-111, an antiangiogenic virotherapy, in patients with advanced solid tumorsAndrew J Brenner, Yael C Cohen, Eyal Breitbart, et al.
Stem Cells (Dayton, Ohio)|January 20, 2021
Activation of estrogen receptor beta signaling reduces stemness of glioma stem cellsGangadhara R Sareddy, Uday P Pratap, Prabhakar Pitta Venkata, et al.
Journal of Neuro-Oncology|June 26, 2015
VB-111: a novel anti-vascular therapeutic for glioblastoma multiformeAleksandra Gruslova, David A Cavazos, Jessica R Miller, et al.
Pageof 6